Quantifying how MHC polymorphism prevents pathogens from adapting to the antigen presentation pathway

Epidemics

Volumn 2, Issue 3, 2010, Pages 99-108

  Schmid, B V ^a,b   Kesmir, C ^b,c   de Boer, R J ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adaptation; CTL epitopes; HIV 1; MHC class I; Population level; Proteasome

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEASOME;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EVOLUTIONARY ADAPTATION; GENE MUTATION; GENETIC POLYMORPHISM; HOST; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SIMULATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS IMMUNITY; VIRUS TRANSMISSION; WILD TYPE;

ALLELES; ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; EPITOPES; HIV INFECTIONS; HIV-1; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MODELS, IMMUNOLOGICAL; POLYMORPHISM, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; VIRUS DISEASES;

EID: 77956094445     PISSN: 17554365     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.epidem.2010.05.003     Document Type: Article

References (54)

1. Althaus C.L., de Boer R.J. Dynamics of immune escape during HIV/SIV infection. PLoS Comput. Biol. 2008, 4(7):e1000103. URL http://dx.doi.org/10.1371/journal.pcbi.1000103.
2. Anzai T., Shiina T., Kimura N., Yanagiya K., Kohara S., Shigenari A., Yamagata T., Kulski J.K., Naruse T.K., Fujimori Y., Fukuzumi Y., Yamazaki M., Tashiro H., Iwamoto C., Umehara Y., Imanishi T., Meyer A., Ikeo K., Gojobori T., Bahram S., Inoko H. Comparative sequencing of human and chimpanzee MHC class I regions unveils insertions/deletions as the major path to genomic divergence. Proc. Natl. Acad. Sci. U S A 2003, 100(13):7708-7713. Jun, URL http://dx.doi.org/10.1073/pnas.1230533100.
3. Asquith B., Edwards C.T.T., Lipsitch M., McLean A.R. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 2006, 4(4):e90. Apr, URL http://dx.doi.org/10.1371/journal.pbio.0040090.
4. Assarsson E., Sidney J., Oseroff C., Pasquetto V., Bui H.-H., Frahm N., Brander C., Peters B., Grey H., Sette A. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J. Immunol. 2007, 178(12):7890-7901. Jun.
5. Barouch D.H., Powers J., Truitt D.M., Kishko M.G., Arthur J.C., Peyerl F.W., Kuroda M.J., Gorgone D.A., Lifton M.A., Lord C.I., Hirsch V.M., Montefiori D.C., Carville A., Mansfield K.G., Kunstman K.J., Wolinsky S.M., Letvin N.L. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat. Immunol. 2005, 6(3):247-252. Mar, URL http://dx.doi.org/10.1038/ni1167.
6. Borghans J.A.M., Beltman J.B., de Boer R.J. MHC polymorphism under host-pathogen coevolution. Immunogenetics 2004, 55(11):732-739. Feb, URL http://dx.doi.org/10.1007/s00251-003-0630-5.
7. Brander C., Yang O.O., Jones N.G., Lee Y., Goulder P., Johnson R.P., Trocha A., Colbert D., Hay C., Buchbinder S., Bergmann C.C., Zweerink H.J., Wolinsky S., Blattner W.A., Kalams S.A., Walker B.D. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. J. Virol. 1999, 73(12):10191-10198. Dec.
8. Burgevin A., Saveanu L., Kim Y., Barilleau E., Kotturi M., Sette A., van Endert P., Peters B. A detailed analysis of the murine TAP transporter substrate specificity. PLoS ONE 2008, 3(6):e2402. URL http://dx.doi.org/10.1371/journal.pone.0002402.
9. Burroughs N.J., de Boer R.J., Keşmir C. Discriminating self from nonself with short peptides from large proteomes. Immunogenetics 2004, 56(5):311-320. Aug, URL http://dx.doi.org/10.1007/s00251-004-0691-0.
10. Carnes B.A., Holden L.R., Olshansky S.J., Witten M.T., Siegel J.S. Mortality partitions and their relevance to research on senescence. Biogerontology 2006, 7(4):183-198. Aug, URL http://dx.doi.org/10.1007/s10522-006-9020-3.
11. Carrington M., Nelson G.W., Martin M.P., Kissner T., Vlahov D., Goedert J.J., Kaslow R., Buchbinder S., Hoots K., O'Brien S.J. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999, 283(5408):1748-1752. Mar.
12. Chakraborty H., Sen P.K., Helms R.W., Vernazza P.L., Fiscus S.A., Eron J.J., Patterson B.K., Coombs R.W., Krieger J.N., Cohen M.S. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001, 15(5):621-627. Mar.
13. Costin J.M. Cytopathic mechanisms of HIV-1. Virol. J. 2007, 4:100. URL http://dx.doi.org/10.1186/1743-422X-4-100.
14. Davenport M.P., Loh L., Petravic J., Kent S.J. Rates of HIV immune escape and reversion: implications for vaccination. Trends Microbiol. 2008, 16(12):561-566. Dec, URL http://dx.doi.org/10.1016/j.tim.2008.09.001.
15. Doherty P.C., Zinkernagel R.M. Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 1975, 256(5512):50-52. Jul.
16. Dugan G.E., Hewitt E.W. Structural and functional dissection of the human cytomegalovirus immune evasion protein us6. J. Virol. 2008, 82(7):3271-3282. Apr, URL http://dx.doi.org/10.1128/JVI.01705-07.
17. Frahm N., Yusim K., Suscovich T.J., Adams S., Sidney J., Hraber P., Hewitt H.S., Linde C.H., Kavanagh D.G., Woodberry T., Henry L.M., Faircloth K., Listgarten J., Kadie C., Jojic N., Sango K., Brown N.V., Pae E., Zaman M.T., Bihl F., Khatri A., John M., Mallal S., Marincola F.M., Walker B.D., Sette A., Heckerman D., Korber B.T., Brander C. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur. J. Immunol. 2007, 37(9):2419-2433. Sep, URL http://dx.doi.org/10.1002/eji.200737365.
18. Friedrich T.C., Dodds E.J., Yant L.J., Vojnov L., Rudersdorf R., Cullen C., Evans D.T., Desrosiers R.C., Moth B.R., Sidney J., Sette A., Kunstman K., Wolinsky S., Piatak M., Lifson J., Hughes A.L., Wilson N., O'Connor D.H., Watkins D.I. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 2004, 10(3):275-281. Mar, URL http://dx.doi.org/10.1038/nm998.
19. Gompertz B. On the nature of the function expressive of the law of human mortality. Philos. Trans. R. Soc. Lond. 1825, 36:513-585.
20. Goonetilleke N., Liu M.K.P., Salazar-Gonzalez J.F., Ferrari G., Giorgi E., Ganusov V.V., Keele B.F., Learn G.H., Turnbull E.L., Salazar M.G., Weinhold K.J., Moore S., B.C.H.A.V.I.C.C., Letvin N., Haynes B.F., Cohen M.S., Hraber P., Bhattacharya T., Borrow P., Perelson A.S., Hahn B.H., Shaw G.M., Korber B.T., McMichael A.J. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 2009, 206(6):1253-1272. Jun, URL http://dx.doi.org/10.1084/jem.20090365.
21. Groothuis T.A.M., Griekspoor A.C., Neijssen J.J., Herberts C.A., Neefjes J.J. MHC class I alleles and their exploration of the antigen-processing machinery. Immunol. Rev. 2005, 207:60-76. Oct, URL http://dx.doi.org/10.1111/j.0105-2896.2005.00305.x.
22. Hallén A. Gompertz law and aging as exclusion effects. Biogerontology 2007, 8(5):605-612. Oct, URL http://dx.doi.org/10.1007/s10522-007-9087-5.
23. Herbeck J.T., Nickle D.C., Learn G.H., Gottlieb G.S., Curlin M.E., Heath L., Mullins J.I. Human immunodeficiency virus type 1 ENV evolves toward ancestral states upon transmission to a new host. J. Virol. 2006, 80(4):1637-1644. Feb, URL http://dx.doi.org/10.1128/JVI.80.4.1637-1644.2006.
24. Hoof I., Keşmir C., Lund O., Nielsen M. Humans with chimpanzee-like major histocompatibility complex-specificities control HIV-1 infection. AIDS 2008, 22(11):1299-1303. Jul, URL http://dx.doi.org/10.1097/QAD.0b013e328302f39f.
25. Kawashima Y., Pfafferott K., Frater J., Matthews P., Payne R., Addo M., Gatanaga H., Fujiwara M., Hachiya A., Koizumi H., Kuse N., Oka S., Duda A., Prendergast A., Crawford H., Leslie A., Brumme Z., Brumme C., Allen T., Brander C., Kaslow R., Tang J., Hunter E., Allen S., Mulenga J., Branch S., Roach T., John M., Mallal S., Ogwu A., Shapiro R., Prado J.G., Fidler S., Weber J., Pybus O.G., Klenerman P., Ndung'u T., Phillips R., Heckerman D., Harrigan P.R., Walker B.D., Takiguchi M., Goulder P. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009, 458(7238):641-645. Apr.
26. Keele B.F., Heuverswyn F.V., Li Y., Bailes E., Takehisa J., Santiago M.L., Bibollet-Ruche F., Chen Y., Wain L.V., Liegeois F., Loul S., Ngole E.M., Bienvenue Y., Delaporte E., Brookfield J.F.Y., Sharp P.M., Shaw G.M., Peeters M., Hahn B.H. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006, 313(5786):523-526. Jul, URL http://dx.doi.org/10.1126/science.1126531.
27. Kesmir C., van Noort V., de Boer R.J., Hogeweg P. Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome. Immunogenetics 2003, 55(7):437-449. Oct, URL http://dx.doi.org/10.1007/s00251-003-0585-6.
28. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., Bishop K., van der Stok M., Nair K., Khan N., Crawford H., Payne R., Leslie A., Prado J., Prendergast A., Frater J., McCarthy N., Brander C., Learn G.H., Nickle D., Rousseau C., Coovadia H., Mullins J.I., Heckerman D., Walker B.D., Goulder P. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 2007, 13(1):46-53. Jan, URL http://dx.doi.org/10.1038/nm1520.
29. Kimura Y., Gushima T., Rawale S., Kaumaya P., Walker C.M. Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis C virus infection. J. Virol. 2005, 79(8):4870-4876. Apr, URL http://dx.doi.org/10.1128/JVI.79.8.4870-4876.2005.
30. Korber B., Muldoon M., Theiler J., Gao F., Gupta R., Lapedes A., Hahn B.H., Wolinsky S., Bhattacharya T. Timing the ancestor of the HIV-1 pandemic strains. Science 2000, 288(5472):1789-1796. Jun.
31. Kotturi M.F., Scott I., Wolfe T., Peters B., Sidney J., Cheroutre H., von Herrath M.G., Buchmeier M.J., Grey H., Sette A. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J. Immunol. 2008, 181(3):2124-2133. Aug.
32. Kwun H.J., da Silva S.R., Shah I.M., Blake N., Moore P.S., Chang Y. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J. Virol. 2007, 81(15):8225-8235. Aug, URL http://dx.doi.org/10.1128/JVI.00411-07.
33. Langefors A., Lohm J., Grahn M., Andersen O., von Schantz T. Association between major histocompatibility complex class IIB alleles and resistance to Aeromonas salmonicida in Atlantic salmon. Proc. Biol. Sci. 2001, 268(1466):479-485. Mar.
34. Larsen M.V., Lundegaard C., Lamberth K., Buus S., Brunak S., Lund O., Nielsen M. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur. J. Immunol. 2005, 35(8):2295-2303. Aug, URL http://dx.doi.org/10.1002/eji.200425811.
35. Lavreys L., Baeten J.M., Chohan V., McClelland R.S., Hassan W.M., Richardson B.A., Mandaliya K., Ndinya-Achola J.O., Overbaugh J. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin. Infect. Dis. 2006, 42(9):1333-1339. May, URL http://dx.doi.org/10.1086/503258.
36. Leslie A., Kavanagh D., Honeyborne I., Pfafferott K., Edwards C., Pillay T., Hilton L., Thobakgale C., Ramduth D., Draenert R., Gall S.L., Luzzi G., Edwards A., Brander C., Sewell A.K., Moore S., Mullins J., Moore C., Mallal S., Bhardwaj N., Yusim K., Phillips R., Klenerman P., Korber B., Kiepiela P., Walker B., Goulder P. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J. Exp. Med. 2005, 201(6):891-902. Mar, URL http://dx.doi.org/10.1084/jem.20041455.
37. Mathunjwa T.R., Gary F.A. Women and HIV/AIDS in the kingdom of Swaziland: culture and risks. J. Natl. Black Nurses Assoc. 2006, 17(2):39-46. Dec.
38. Nijhuis M., Schuurman R., de Jong D., Erickson J., Gustchina E., Albert J., Schipper P., Gulnik S., Boucher C.A. Increased fitness of drug resistant hiv-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 1999, 13(17):2349-2359. Dec.
39. Piatak M., Saag M.S., Yang L.C., Clark S.J., Kappes J.C., Luk K.C., Hahn B.H., Shaw G.M., Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259(5102):1749-1754. Mar.
40. Robinson J., Waller M.J., Fail S.C., Marsh S.G.E. The IMGT/HLA and IPD databases. Hum. Mutat. 2006, 27(12):1192-1199. Dec, URL http://dx.doi.org/10.1002/humu.20406.
41. Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Giorgi E.E., Li H., Decker J.M., Wang S., Baalwa J., Kraus M.H., Parrish N.F., Shaw K.S., Guffey M.B., Bar K.J., Davis K.L., Ochsenbauer-Jambor C., Kappes J.C., Saag M.S., Cohen M.S., Mulenga J., Derdeyn C.A., Allen S., Hunter E., Markowitz M., Hraber P., Perelson A.S., Bhattacharya T., Haynes B.F., Korber B.T., Hahn B.H., Shaw G.M. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 2009, 206(6):1273-1289. Jun, URL http://dx.doi.org/10.1084/jem.20090378.
42. Sayers E.W., Barrett T., Benson D.A., Bryant S.H., Canese K., Chetvernin V., Church D.M., DiCuccio M., Edgar R., Federhen S., Feolo M., Geer L.Y., Helmberg W., Kapustin Y., Landsman D., Lipman D.J., Madden T.L., Maglott D.R., Miller V., Mizrachi I., Ostell J., Pruitt K.D., Schuler G.D., Sequeira E., Sherry S.T., Shumway M., Sirotkin K., Souvorov A., Starchenko G., Tatusova T.A., Wagner L., Yaschenko E., Ye J. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2009, 37:D5-D16. Jan, (Database issue) URL http://dx.doi.org/10.1093/nar/gkn741.
43. Schmid B.V., Keşmir C., de Boer R.J. The specificity and polymorphism of the MHC Class I prevents the global adaptation of HIV-1 to the monomorphic proteasome and TAP. PLoS ONE 2008, 3(10):e3525. URL http://dx.doi.org/10.1371/journal.pone.0003525.
44. Schneidewind A., Brumme Z.L., Brumme C.J., Power K.A., Reyor L.L., O'Sullivan K., Gladden A., Hempel U., Kuntzen T., Wang Y.E., Oniangue-Ndza C., Jessen H., Markowitz M., Rosenberg E.S., Skaly R.-P., Kelleher A.D., Walker B.D., Allen T.M. Transmission and long-term stability of compensated CD8 escape mutations. J. Virol. 2009, 83(8):3993-3997. Apr, URL http://dx.doi.org/10.1128/JVI.01108-08.
45. Shimizu N., Takeuchi Y., Naruse T., Inagaki M., Moriyama E., Gojobori T., Hoshino H. Six strains of human immunodeficiency virus type 1 isolated in Japan and their molecular phylogeny. J. Mol. Evol. 1992, 35(4):329-336. Oct.
46. Slade R.W., McCallum H.I. Overdominant vs. frequency-dependent selection at MHC loci. Genetics 1992, 132(3):861-864. Nov.
47. Tenzer S., Peters B., Bulik S., Schoor O., Lemmel C., Schatz M.M., Kloetzel P.-M., Rammensee H.-G., Schild H., Holzhütter H.-G. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell. Mol. Life Sci. 2005, 62(9):1025-1037. May, URL http://dx.doi.org/10.1007/s00018-005-4528-2.
48. Trachtenberg E., Korber B., Sollars C., Kepler T.B., Hraber P.T., Hayes E., Funkhouser R., Fugate M., Theiler J., Hsu Y.S., Kunstman K., Wu S., Phair J., Erlich H., Wolinsky S. Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 2003, 9(7):928-935. Jul, URL http://dx.doi.org/10.1038/nm893.
49. van Ballegooijen M., Bogaards J.A., Weverling G.-J., Boerlijst M.C., Goudsmit J. AIDS vaccines that allow HIV-1 to infect and escape immunologic control: a mathematic analysis of mass vaccination. J. Acquir. Immune Defic. Syndr. 2003, 34(2):214-220. Oct.
50. Vider-Shalit T., Almani M., Sarid R., Louzoun Y. The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire. AIDS 2009, 23(11):1311-1318. Jul, URL http://dx.doi.org/10.1097/QAD.0b013e32832c492a.
51. Wawer M.J., Gray R.H., Sewankambo N.K., Serwadda D., Li X., Laeyendecker O., Kiwanuka N., Kigozi G., Kiddugavu M., Lutalo T., Nalugoda F., Wabwire-Mangen F., Meehan M.P., Quinn T.C. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 2005, 191(9):1403-1409. May, URL http://dx.doi.org/10.1086/429411.
52. Wertheim J.O., Worobey M. Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2. PLoS Comput. Biol. 2009, 5(5):e1000377. May, URL http://dx.doi.org/10.1371/journal.pcbi.1000377.
53. Worobey M., Gemmel M., Teuwen D.E., Haselkorn T., Kunstman K., Bunce M., Muyembe J.-J., Kabongo J.-M.M., Kalengayi R.M., Marck E.V., Gilbert M.T.P., Wolinsky S.M. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008, 455(7213):661-664. Oct, URL http://dx.doi.org/10.1038/nature07390.
54. Yokomaku Y., Miura H., Tomiyama H., Kawana-Tachikawa A., Takiguchi M., Kojima A., Nagai Y., Iwamoto A., Matsuda Z., Ariyoshi K. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. J. Virol. 2004, 78(3):1324-1332. Feb.